Smiths Medical and WuXi AppTec are exiting infusion pump developer Ivenix in an acquisition that could reach $240m, while AI software developer Syntiant raised $55m from investors including Renesas.

Funding

Syntiant, a US-based provider of edge artificial intelligence software, has completed a $55m funding round that included semiconductor manufacturer Renesas Electronics Corporation. The corporate participated alongside Millennium Technology Value Partners, Mirae Asset Capital and undisclosed new and existing investors.

4C Medical Technologies, a US-based developer of treatments for structural heart disease, closed a $35.4m series C round yesterday led by medical device producer MicroPort CardioFlow Medtech Corporation. The cash will support technology development and the expansion of 4C’s product…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn